The Kobe University Human Intestinal Microbiota Model for gut intervention studies
- PMID: 33718974
- DOI: 10.1007/s00253-021-11217-x
The Kobe University Human Intestinal Microbiota Model for gut intervention studies
Abstract
The human gut harbors a complex microbial community that performs a range of metabolic, physiological, and immunological functions. The host and its inhabiting microorganisms are often referred to as a "superorganism." Dysbiosis of gut microflora has been associated with the pathogenesis of intestinal disorders including inflammatory bowel disease, colorectal cancer, and extra-intestinal disorders such as cardiovascular disease. Therefore, gut microbiome interventions are important for the prevention and treatment of diseases. However, ethical, economic, scientific, and time constraints limit the outcome of human intervention or animal studies targeting gut microbiota. We recently developed an in vitro batch fermentation model (the Kobe University Human Intestinal Microbiota Model, KUHIMM) that is capable of hosting a majority of gut microbial species in humans and also detects the metabolites produced by microorganisms in real time. In this mini review, we elucidated the characteristics of the KUHIMM and its applicability in analyzing the effect of diet, drugs, probiotics, and prebiotics on intestinal bacteria. In addition, we introduce as examples its application to disease models, such as ulcerative colitis, in which intestinal bacteria are intricately involved in the process of pathogenesis. We also discuss the potential of the KUHIMM in precision medicine. KEY POINTS: • In vitro gut fermentation model to simulate human colonic microbiota • Screening of potential prebiotics and probiotic candidates in healthy model • Construction of disease models of ulcerative colitis and coronary artery disease.
Keywords: Coronary artery disease; Gut; In vitro model; Microbiota; Ulcerative colitis.
Similar articles
-
The mutual interplay of gut microbiota, diet and human disease.FEBS J. 2020 Mar;287(5):833-855. doi: 10.1111/febs.15217. Epub 2020 Feb 3. FEBS J. 2020. PMID: 31955527 Review.
-
Inflammatory Bowel Diseases: The Role of Gut Microbiota.Curr Pharm Des. 2020;26(25):2951-2961. doi: 10.2174/1381612826666200420144128. Curr Pharm Des. 2020. PMID: 32310042 Review.
-
Novel insights in the relationship of gut microbiota and coronary artery diseases.Crit Rev Food Sci Nutr. 2022;62(14):3738-3750. doi: 10.1080/10408398.2020.1868397. Epub 2021 Jan 5. Crit Rev Food Sci Nutr. 2022. PMID: 33399007 Review.
-
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.Anticancer Agents Med Chem. 2022;22(4):605-628. doi: 10.2174/1871520621999201210220442. Anticancer Agents Med Chem. 2022. PMID: 33305713 Review.
-
Interactions of probiotics and prebiotics with the gut microbiota.Prog Mol Biol Transl Sci. 2020;171:265-300. doi: 10.1016/bs.pmbts.2020.03.008. Epub 2020 Apr 24. Prog Mol Biol Transl Sci. 2020. PMID: 32475525
Cited by
-
International standard of Traditional Chinese Medicine techniques: the operating specification for Traditional Chinese Medicine enema (2022).J Tradit Chin Med. 2024 Oct;44(5):1035-1043. doi: 10.19852/j.cnki.jtcm.2024.05.010. J Tradit Chin Med. 2024. PMID: 39380235 Free PMC article.
-
Effects of blackcurrant extract on indole and ammonia productions in an in vitro human fecal culture model.Biosci Microbiota Food Health. 2024;43(1):23-28. doi: 10.12938/bmfh.2022-094. Epub 2023 Sep 7. Biosci Microbiota Food Health. 2024. PMID: 38188663 Free PMC article.
-
Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension.Geroscience. 2023 Dec;45(6):3475-3490. doi: 10.1007/s11357-023-00851-0. Epub 2023 Jun 30. Geroscience. 2023. PMID: 37389698 Free PMC article. Review.
-
Unraveling the microbial mysteries: gut microbiota's role in ulcerative colitis.Front Nutr. 2025 Feb 10;12:1519974. doi: 10.3389/fnut.2025.1519974. eCollection 2025. Front Nutr. 2025. PMID: 39996003 Free PMC article. Review.
-
Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission.Front Nutr. 2021 Dec 28;8:778542. doi: 10.3389/fnut.2021.778542. eCollection 2021. Front Nutr. 2021. PMID: 35028306 Free PMC article.
References
-
- Aguirre M, Eck A, Koenen ME, Savelkoul PHM, Budding AE, Venema K (2016) Diet drives quick change in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model. Res Microbiol 167:114–125. https://doi.org/10.1016/j.resmic.2015.09.006 - DOI - PubMed
-
- Bambery B, Selgelid M, Weijer C, Savulescu J, Pollard AJ (2016) Ethical criteria for human challenge studies in infectious diseases. Public Health Ethics 9:92–103. https://doi.org/10.1093/phe/phv026 - DOI - PubMed
-
- Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26:26191. https://doi.org/10.3402/mehd.v26.26191 - DOI - PubMed
-
- Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM (2019) Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 321:156–164. https://doi.org/10.1001/jama.2018.20046 - DOI - PubMed - PMC
-
- Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221–1227. https://doi.org/10.1136/gut.28.10.1221 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources